NCT06830629

Brief Summary

This is purpose of this study is to evaluate the safety, tolerability, and effect on Albuminuria of MZE829 in Adults with APOL1 Kidney Disease

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for phase_2

Timeline
4mo left

Started Feb 2025

Geographic Reach
3 countries

81 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
Feb 2025Sep 2026

Study Start

First participant enrolled

February 5, 2025

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

February 7, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 17, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

April 17, 2026

Status Verified

April 1, 2026

Enrollment Period

1.6 years

First QC Date

February 7, 2025

Last Update Submit

April 16, 2026

Conditions

Keywords

APOL1-mediated kidney disease (AMKD)APOL1 kidney disease (AKD)

Outcome Measures

Primary Outcomes (1)

  • Safety and tolerability as assessed by incidence of adverse events (AEs)

    Day 1 to Week 12

Secondary Outcomes (2)

  • Percent participants with ≥30% reduction from baseline in UACR at Week 12

    Day 1 to Week 12

  • Geometric mean plasma drug concentrations

    Day 1 to Week 12

Study Arms (1)

MZE829

EXPERIMENTAL

Cohort 1: Chronic kidney disease with concurrent diabetes Cohort 2: Chronic kidney disease without concurrent diabetes

Drug: MZE829

Interventions

MZE829DRUG

Capsules for oral administration

MZE829

Eligibility Criteria

Age18 Years - 68 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • APOL1 high risk genotype of G1/G1, G2/G2, or G1/G2
  • Chronic kidney disease with persistent albuminuria

You may not qualify if:

  • Organ or bone marrow transplantation
  • History of cancer within past 2 years, excepted for treated non-melanoma skin cancer, stage 0 cervical cancer, or stage 1 prostate cancer
  • Conditions that may alter drug absorption, e.g., history of bariatric surgery
  • Type I diabetes
  • Pregnant or currently nursing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (81)

Research Site

Decatur, Alabama, 35601, United States

RECRUITING

Research Site

Huntsville, Alabama, 35805, United States

RECRUITING

Research Site

Montgomery, Alabama, 36106, United States

RECRUITING

Research Site

Montgomery, Alabama, 36117, United States

RECRUITING

Research Site

Granada Hills, California, 91344, United States

RECRUITING

Research Site

Bloomfield, Connecticut, 06112, United States

RECRUITING

Research Site

Atlantis, Florida, 33462, United States

RECRUITING

Research Site

Brandon, Florida, 33511, United States

RECRUITING

Research Site

Brooksville, Florida, 34613, United States

RECRUITING

Research Site

Hollywood, Florida, 33024, United States

RECRUITING

Research Site

Melbourne, Florida, 32901, United States

RECRUITING

Research Site

Miami Lakes, Florida, 33014, United States

RECRUITING

Research Site

Orlando, Florida, 32822, United States

RECRUITING

Research Site

Atlanta, Georgia, 30309, United States

RECRUITING

Research Site

College Park, Georgia, 30349, United States

RECRUITING

Research Site

Cordele, Georgia, 31015, United States

RECRUITING

Research Site

Lithia Springs, Georgia, 30122, United States

RECRUITING

Research Site

Macon, Georgia, 31210, United States

RECRUITING

Research Site

Riverdale, Georgia, 30274, United States

RECRUITING

Research Site

Riverdale, Georgia, 30296, United States

RECRUITING

Research Site

Savannah, Georgia, 31406, United States

RECRUITING

Research Site

Snellville, Georgia, 30078, United States

RECRUITING

Research Site

Chicago, Illinois, 60616, United States

RECRUITING

Research Site

Chicago, Illinois, 60643, United States

RECRUITING

Research Site

Kansas City, Kansas, 66112, United States

RECRUITING

Research Site

Bowling Green, Kentucky, 42101, United States

RECRUITING

Research Site

Louisville, Kentucky, 40205, United States

RECRUITING

Research Site

Arnold, Maryland, 21012, United States

RECRUITING

Research Site

Lutherville, Maryland, 21093, United States

RECRUITING

Research Site

Oxon Hill, Maryland, 20745, United States

RECRUITING

Research Site

Dearborn, Michigan, 48126, United States

RECRUITING

Research Site

Flint, Michigan, 48503, United States

RECRUITING

Research Site

Pontiac, Michigan, 48341, United States

RECRUITING

Research Site

Saint Joseph, Michigan, 49085, United States

RECRUITING

Research Site

Shelby, Michigan, 48092, United States

RECRUITING

Research Site

Minneapolis, Minnesota, 55404, United States

RECRUITING

Research Site

Tupelo, Mississippi, 38801, United States

RECRUITING

Research Site

City of Saint Peters, Missouri, 63376, United States

RECRUITING

Research Site

St Louis, Missouri, 63103, United States

RECRUITING

Research Site

Las Vegas, Nevada, 89107, United States

RECRUITING

Research Site

Buffalo, New York, 14203, United States

RECRUITING

Research Site

Laurelton, New York, 11413, United States

RECRUITING

Research Site

Maspeth, New York, 11378, United States

RECRUITING

Research Site

New York, New York, 10021, United States

RECRUITING

Research Site

Newburgh, New York, 12550, United States

RECRUITING

Research Site

Durham, North Carolina, 27708, United States

RECRUITING

Research Site

Fayetteville, North Carolina, 28304, United States

RECRUITING

Research Site

Greensboro, North Carolina, 27405, United States

RECRUITING

Research Site

Shelby, North Carolina, 28150, United States

RECRUITING

Research Site

Cincinnati, Ohio, 45267, United States

RECRUITING

Research Site

Cleveland, Ohio, 44106, United States

RECRUITING

Research Site

Cleveland, Ohio, 44195, United States

RECRUITING

Research Site

Columbus, Ohio, 43215, United States

RECRUITING

Research Site

Ardmore, Oklahoma, 73401, United States

RECRUITING

Research Site

Philadelphia, Pennsylvania, 19104, United States

RECRUITING

Research Site

Philadelphia, Pennsylvania, 19107, United States

RECRUITING

Research Site

Upland, Pennsylvania, 19013, United States

RECRUITING

Research Site

Columbia, South Carolina, 29203, United States

RECRUITING

Research Site

Spartanburg, South Carolina, 29302, United States

RECRUITING

Research Site

Spartanburg, South Carolina, 29306, United States

RECRUITING

Research Site

Chattanooga, Tennessee, 37404, United States

RECRUITING

Research Site

Dallas, Texas, 75230, United States

RECRUITING

Research Site

Dallas, Texas, 75246, United States

RECRUITING

Research Site

Greenville, Texas, 75402, United States

RECRUITING

Research Site

Houston, Texas, 77030, United States

RECRUITING

Research Site

Houston, Texas, 77054, United States

RECRUITING

Research Site

Houston, Texas, 77099, United States

RECRUITING

Research Site

McKinney, Texas, 75069, United States

RECRUITING

Research Site

San Antonio, Texas, 78251, United States

RECRUITING

Research Site

Shenandoah, Texas, 77384, United States

RECRUITING

Research Site

Sherman, Texas, 75092, United States

RECRUITING

Research Site

Norfolk, Virginia, 23504, United States

RECRUITING

Research Site

Créteil, 94010, France

RECRUITING

Research Site

Lyon, 69347, France

RECRUITING

Research Site

Paris, 75015, France

RECRUITING

Research Site

Paris, 75020, France

RECRUITING

Research Site

Saint-Ouen, 93400, France

RECRUITING

Research Site

Leicester, LE5 4PW, United Kingdom

RECRUITING

Research Site

London, NW3 2QG, United Kingdom

RECRUITING

Research Site

London, SE19RT, United Kingdom

RECRUITING

Research Site

London, SE59RS, United Kingdom

RECRUITING

Study Officials

  • Medical Director

    Maze Therapeutics

    STUDY DIRECTOR

Central Study Contacts

Maze Therapeutics

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 7, 2025

First Posted

February 17, 2025

Study Start

February 5, 2025

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

April 17, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations